
Transactions: Sweden
Filter


Redemption offer in JM (SE) — SEK 1 billion

Secondary placing of 5.7 million shares in Intrum Justitia (SE) — EUR 35 million

Convertible rights issue in Elekta (SE) — SEK 467 million

Initial public offering of BioInvent International AB (SE) — SEK 372 million

Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million

New share issue in Biotage AB (SE) — SEK 34 million

Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 48 million

Redemption in Castellum (SE) — SEK 700 million

Redemption offer in JM (SE) — SEK 1 billion

Secondary placing of 3.5 million shares in Intrum Justitia (SE) — SEK 184 million
